Back to Search
GEORGE RETSCH-BOGART, MD
MD
Pediatric Pulmonology Physician
NPI: 1902986391Individual
Specialties, Licenses & Credentials
Pediatric Pulmonology PhysicianPrimary
Pediatrics — Pediatric Pulmonology
Code: 2080P0214X
0000-30461(NC)
Research & Publications (17)
Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.
PMID 19420195·Chest·2009
4-observational
A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.
PMID 18041081·Pediatr Pulmonol·2008
3-trial
Update on cystic fibrosis-related bone disease: a special focus on children.
PMID 19651384·Paediatr Respir Rev·2009
6-review
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.
PMID 19470318·Contemp Clin Trials·2009
4-observational
Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.
PMID 18658109·Am J Respir Crit Care Med·2008
4-observational
Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
PMID 17647287·Pediatr Pulmonol·2007
8-other
Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis.
PMID 17534969·Pediatr Pulmonol·2007
8-other
Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis.
PMID 17303797·Am J Respir Crit Care Med·2007
3-trial
Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis.
PMID 16703579·Pediatr Pulmonol·2006
2-rct
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis.
PMID 15704203·Pediatr Pulmonol·2005
3-trial
Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
PMID 15573395·Pediatr Pulmonol·2005
3-trial
Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.
PMID 12969869·Am J Respir Crit Care Med·2003
3-trial
Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.
PMID 12480612·Am J Respir Crit Care Med·2003
3-trial
Long term results of lung transplantation for cystic fibrosis.
PMID 12297180·Eur J Cardiothorac Surg·2002
8-other
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.
PMID 11598606·J Pediatr·2001
3-trial
Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen.
PMID 11288217·Pediatr Pulmonol·2001
5-case
Pharmacokinetics of ibuprofen enantiomers in children with cystic fibrosis.
PMID 10934670·J Clin Pharmacol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, ND 27599 - Phone
- (919) 966-4131
Quick Facts
- NPI
- 1902986391
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile